| Literature DB >> 29535790 |
Masood Fereidoonnezhad1,2, Zeinab Faghih2, Ayyub Mojaddami1,2, Zahra Rezaei2, Amirhossein Sakhteman2,3.
Abstract
Dichloroacetate (DCA) is a simple and small anticancer drug that arouses the activity of the enzyme pyruvate dehydrogenase (PDH) through inhibition of the enzyme pyruvate dehydrogenase kinases (PDK1-4). DCA can selectively promote mitochondria-regulated apoptosis, depolarizing the hyperpolarized inner mitochondrial membrane potential to normal levels, inhibit tumor growth and reduce proliferation by shifting the glucose metabolism in cancer cells from anaerobic to aerobic glycolysis. In this study, a series of DCA analogues were applied to quantitative structure-activity relationship (QSAR) analysis. A collection of chemometrics methods such as multiple linear regression (MLR), factor analysis-based multiple linear regression (FA-MLR), principal component regression (PCR), and partial least squared combined with genetic algorithm for variable selection (GA-PLS) were applied to make relations between structural characteristics and cytotoxic activities of a variety of DCA analogues. The best multiple linear regression equation was obtained from genetic algorithms partial least squares, which predict 90% of variances. Based on the resulted model, an in silico-screening study was also conducted and new potent lead compounds based on new structural patterns were designed. Molecular docking as well as protein ligand interaction fingerprints (PLIF) studies of these compounds were also investigated and encouraging results were acquired. There was a good correlation between QSAR and docking results.Entities:
Keywords: DCA; Descriptor analysis; Docking; PLIF studies; QSAR; in silico screening
Year: 2017 PMID: 29535790 PMCID: PMC5610753
Source DB: PubMed Journal: Iran J Pharm Res ISSN: 1726-6882 Impact factor: 1.696
Chemical structure of the N-arylphenyl-2, 2-dichloroacetamideanalogues used in this study and their docking binding energy, experimental and cross-validated predicted activity (by GA-PLS) for cytotoxic activity
|
|
Cross-validated prediction by
The results of different QSAR models with different type of dependant variables
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| MLR |
| pIC50 = 0.010G(O..O) (±0.003) - 0.376nPhX (±0.058) + 0.265DipY(±0.072) -1.574GATS7v (±0.258) + 1.076MATS2e (±0.362)+ 0.205nROR (±0.063) + 0.997MATS7e(±0..401)+7.562 (±0.488) | 27 | 0.917 | 0.76 | 0.159 | 2.78 | 25.0 | 0.12 | 0.70 |
| FA-MLR |
| pIC50 = 2.152MATS7v(±0.537) + 0.230DipY(±0.083) + 0.244nROR (±0.048) + 0.020Ss (±0.003) +3.538 (±0.204) | 27 | 0.895 | 0.81 | 0.197 | 3.29 | 19.8 | 0.22 | 0.69 |
| PCRA |
| pIC50 = 0.240 FAC1 (±0.048) + 0.139 FAC2 (±0.048) + 0.114 FAC4 (±0.048) + 0.117 FAC7 (±0.048) + 0.103 FAC9 (±0.048) + 4.969 (±0.047) | 27 | 0.906 | 0.87 | 0.168 | 3.24 | 19.8 | 0.27 | 0.71 |
| GA-PLS |
| pIC50 = -20.126X3A (±7.555)+3.685MATS7v (±0.391)+ 2.655MATS5p (±0.471) + 0.319DipY(±0.053) + 0.230H-048 (±0.036) -1.084MATS6e (±0.304) -0.637 ASP (±0.234)+8.553 (±1.397) | 27 | 0.943 | 0.82 | 0.148 | 2.99 | 31.7 | 0.09 | 0.87 |
Number of molecules of training set used to derive the QSAR modelT
Correlation coefficient (R2) matrix for descriptors represented in multiple linear regression eqn 1.
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|
| MATS2e | 1 | -0.160 | 0.217 | 0.315 | -0.192 | -0.207 | -0.294 |
| MATS7e | 1 | 0.130 | 0.013 | 0.003 | -0.048 | 0.205 | |
| GATS7v | 1 | 0.088 | 0.209 | 0.090 | 0.075 | ||
| DipY | 1 | -0.233 | -0.088 | -0.218 | |||
| nROR | 1 | -0.134 | 0.227 | ||||
| nPhX | 1 | -0.159 | |||||
| G(O..O) | 1 |
Factor loadings of some significant descriptors after VARIMAX rotation
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| pIC50 | 0.596 | 0.476 | 0.389 | 0.218 | -0.169 | 0.939 | |
| Mp | -0.578 | -0.397 | -0.210 | 0.082 | -0.049 | 0.993 | -0.021 |
| G(O..O) | 0.679 | 0.445 | -0.463 | -0.022 | -0.023 | 0.988 | 0.345 |
| qpos | 0.821 | 0.515 | -0.175 | 0.083 | -0.069 | 0.984 | 0.234 |
| H-048 | 0.310 | 0.371 | -0.552 | -0.288 | -0.128 | 0.956 | 0.561 |
| H-052 | 0.544 | -0.019 | 0.165 | 0.306 | -0.016 | 0.932 | 0.508 |
| nROR | 0.259 | 0.364 | -0.608 | -0.270 | -0.067 | 0.956 | 0.676 |
| nPhX | -0.159 | 0.282 | -0.063 | 0.611 | 0.342 | 0.970 | 0.441 |
| X3A | -0.706 | -0.386 | -0.059 | 0.198 | 0.094 | 0.979 | 0.398 |
| X3AV | -0.078 | -0.757 | 0.026 | -0.125 | 0.162 | 0.965 | -0.243 |
| lop | -0.482 | -0.180 | 0.415 | 0.409 | -0.243 | 0.983 | -0.129 |
| ATS8p | 0.054 | -0.527 | -0.180 | 0.387 | 0.157 | 0.981 | 0.256 |
| GATS6m | -0.581 | -0.431 | -0.133 | 0.052 | 0.001 | 0.940 | 0.436 |
| GATS8m | -0.590 | -0.537 | -0.028 | 0.166 | 0.122 | 0.894 | 0.450 |
| GATS5e | -0.605 | 0.355 | 0.037 | -0.132 | 0.079 | 0.871 | 0.164 |
| GATS8e | -0.817 | -0.100 | 0.113 | 0.055 | 0.027 | 0.830 | 0.237 |
| GATS4p | 0.120 | 0.059 | 0.417 | -0.698 | -0.151 | 0.938 | 0.461 |
| GATS7p | -0.371 | 0.156 | -0.127 | -0.118 | -0.013 | 0.903 | 0.219 |
| GATS4v | 0.035 | 0.086 | -0.111 | -0.050 | 0.603 | 0.965 | 0.065 |
| MATS5p | -0.145 | 0.209 | -0.616 | -0.124 | 0.086 | 0.881 | -0.432 |
| MATS7v | -0.815 | -0.218 | -0.018 | 0.313 | 0.115 | 0.944 | 0.712 |
| MATS4m | -0.288 | 0.114 | -0.008 | 0.053 | -0.008 | 0.993 | 0.349 |
| MATS6m | -0.352 | -0.088 | 0.264 | 0.102 | -0.454 | 0.816 | 0.415 |
| MATS6e | 0.576 | -0.346 | 0.086 | -0.040 | 0.116 | 0.954 | -0.291 |
| MATS7e | 0.637 | 0.047 | 0.038 | -0.098 | -0.198 | 0.858 | -0.123 |
| ASP | -0.907 | -0.012 | -0.017 | 0.019 | -0.072 | 0.971 | -0.293 |
| Ss | 0.708 | 0.586 | 0.232 | 0.122 | 0.032 | 0.997 | 0.608 |
| G(N..F) | -0.310 | 0.721 | 0.488 | -0.046 | 0.258 | 0.992 | 0.341 |
| MAXDP | 0.551 | 0.435 | 0.145 | 0.134 | .264 | 0.954 | 0.326 |
| DipY | -0.027 | -0.210 | 0.357 | -0.144 | -0.693 | 0.774 | 0.632 |
Definitions of molecular descriptors present in the models
|
|
|
|
|---|---|---|
| 1 | ATS8p | Broto-Moreau autocorrelation of a topological structure - lag 8 / weighted by atomic polarizabilities |
| 2 | MATS7v | Moran autocorrelation - lag 7 / weighted by atomic van der Waals volumes |
| 3 | MATS4m | Moran autocorrelation - lag 4 / weighted by atomic masses |
| 4 | MATS6m | Moran autocorrelation - lag 6 / weighted by atomic masses |
| 5 | MATS5p | Moran autocorrelation - lag 5 / weighted by atomic polarizabilities |
| 6 | MATS6e | Moran autocorrelation - lag 6 / weighted by atomic Sanderson electronegativities |
| 7 | MATS7e | Moran autocorrelation - lag 7 / weighted by atomic Sanderson electronegativities |
| 8 | GATS4v | Geary autocorrelation - lag 4 / weighted by atomic van der Waals volumes |
| 9 | GATS7v | Geary autocorrelation - lag 7 / weighted by atomic van der Waals volumes |
| 10 | GATS6m | Geary autocorrelation - lag 6 / weighted by atomic masses |
| 11 | GATS4p | Geary autocorrelation - lag 4 / weighted by atomic polarizabilities |
| 12 | GATS7p | Geary autocorrelation - lag 7 / weighted by atomic polarizabilities |
| 13 | GATS8e | Moran autocorrelation - lag 8 / weighted by atomic Sanderson electronegativities |
| 14 | X3A | average connectivity index chi-3 |
| 15 | X3AV | average valence connectivity index chi-3 |
| 16 | H-048 | H attached to C2(sp3) / C1(sp2) / C0(sp) |
| 17 | H-052 | H attached to C0(sp3) with 1X attached to next C |
| 18 | G(O..O) | sum of geometrical distances between O..O |
| 19 | Lop | Lopping centric index |
| 20 | nPhX | number of X-C on aromatic ring |
| 21 | nROR | number of ethers (aliphatic) |
| 22 | ASP | Asphericity |
| 23 | DMY(DipY) | Molecular dipole moment at Y-direction |
Figure 1Williams plot for the training set and external prediction set for cytotoxic activity of N-arylphenyl-2,2-dichloroacetamide analogues
Structural modification of N-arylphenyl-2, 2-dichloroacetamide analogues and their predicted activities and docking binding energy
|
|
Figure 2Plots of cross-validated predicted values of activity by GA-PLS against the experimental values
Figure 3.Plots of experimental pIC50 values versus docking binding energy
Figure 4Plots of predicted pIC50 values versus docking binding energy
Figure 5Interactions of A) DCA and B) compound 4d with the residues in the binding site of PDK (2BU8) receptor.
Figure 6AuposSOM results for poses of docking.